Prophylaxis With Intrathecal or High-Dose Methotrexate Reduces the Risk of CNS Relapse in DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Cancer Journal